These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 30032237)

  • 1. How well does the process of screening and diagnosis work for HIV-infected persons identified with presumptive tuberculosis who are attending HIV care and treatment clinics in Harare city, Zimbabwe?
    Takarinda KC; Choto R; Sandy C; Apollo T; Duri C; Dube F; Mpofu A; Timire C; Mugurungi O; Makaza V; Tapera R; Harries AD
    Trans R Soc Trop Med Hyg; 2018 Oct; 112(10):450-457. PubMed ID: 30032237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of a clinical diagnostic algorithm for management of ambulatory smear and Xpert MTB/Rif negative HIV infected patients with presumptive pulmonary TB in Uganda: a prospective study.
    Walusimbi S; Semitala F; Bwanga F; Haile M; De Costa A; Davis L; Joloba M; Hoffner S; Kamya M
    Pan Afr Med J; 2016; 23():154. PubMed ID: 27303572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Xpert® MTB/RIF assay and microscopy for the diagnosis of Mycobacterium tuberculosis in Namibia.
    Mavenyengwa RT; Shaduka E; Maposa I
    Infect Dis Poverty; 2017 Jan; 6(1):13. PubMed ID: 28086955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuberculosis case finding using population-based disease surveillance platforms in urban and rural Kenya.
    Bigogo G; Cain K; Nyole D; Masyongo G; Auko JA; Wamola N; Okumu A; Agaya J; Montgomery J; Borgdorff M; Burton D
    BMC Infect Dis; 2018 Jun; 18(1):262. PubMed ID: 29879917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does pre-diagnostic loss to follow-up among presumptive TB patients differ by type of health facility? An operational research from Hwange, Zimbabwe in 2017.
    Padingani M; Kumar A; Tripathy JP; Masuka N; Khumalo S
    Pan Afr Med J; 2018; 31():196. PubMed ID: 31086640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes and Diagnostic Processes in Outpatients with Presumptive Tuberculosis in Zomba District, Malawi.
    van Lettow M; Bedell R; Maosa S; Phiri K; Chan AK; Mwinjiwa E; Kwekwesa A; Kawonga H; Joshua M; Harries AD; van Oosterhout JJ
    PLoS One; 2015; 10(11):e0141414. PubMed ID: 26556045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed diagnosis and treatment of tuberculosis in HIV+ patients in Mozambique: A cost-effectiveness analysis of screening protocols based on four symptom screening, smear microscopy, urine LAM test and Xpert MTB/RIF.
    Orlando S; Triulzi I; Ciccacci F; Palla I; Palombi L; Marazzi MC; Giuliano M; Floridia M; Mancinelli S; Mutemba E; Turchetti G
    PLoS One; 2018; 13(7):e0200523. PubMed ID: 30024890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors and outcomes of mycobacteremia among HIV-infected smear- negative presumptive tuberculosis patients in Uganda.
    Nakiyingi L; Ssengooba W; Nakanjako D; Armstrong D; Holshouser M; Kirenga BJ; Shah M; Mayanja-Kizza H; Joloba ML; Ellner JJ; Dorman SE; Manabe YC
    BMC Infect Dis; 2015 Feb; 15():62. PubMed ID: 25888317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV care among patients with presumptive tuberculosis in Masvingo district of Zimbabwe, 2017: how well are we doing?
    Ndudzo C; Tripathy JP; Tauro F; Sibanda C; Chiramba M; Shamu A; Masinire K; Muchengwa T; Kumar AM
    Pan Afr Med J; 2019; 33():158. PubMed ID: 31565120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening and testing for tuberculosis among the HIV-infected: outcomes from a large HIV programme in western Kenya.
    Owiti P; Onyango D; Momanyi R; Harries AD
    BMC Public Health; 2019 Jan; 19(1):29. PubMed ID: 30621655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic screening for drug-resistant tuberculosis with Xpert(®) MTB/RIF in a referral hospital in Cambodia.
    Lorent N; Kong C; Kim T; Sam S; Thai S; Colebunders R; Rigouts L; Lynen L
    Int J Tuberc Lung Dis; 2015 Dec; 19(12):1528-35. PubMed ID: 26614197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xpert MTB/RIF diagnosis of childhood tuberculosis from sputum and stool samples in a high TB-HIV-prevalent setting.
    Orikiriza P; Nansumba M; Nyehangane D; Bastard M; Mugisha IT; Nansera D; Mwanga-Amumpaire J; Boum Y; Kumbakumba E; Bonnet M
    Eur J Clin Microbiol Infect Dis; 2018 Aug; 37(8):1465-1473. PubMed ID: 29740714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time delay and associated mortality from negative smear to positive Xpert MTB/RIF test among TB/HIV patients: a retrospective study.
    Lisboa M; Fronteira I; Colove E; Nhamonga M; Martins MDRO
    BMC Infect Dis; 2019 Jan; 19(1):18. PubMed ID: 30616533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Test characteristics and potential impact of the urine LAM lateral flow assay in HIV-infected outpatients under investigation for TB and able to self-expectorate sputum for diagnostic testing.
    Peter J; Theron G; Chanda D; Clowes P; Rachow A; Lesosky M; Hoelscher M; Mwaba P; Pym A; Dheda K;
    BMC Infect Dis; 2015 Jul; 15():262. PubMed ID: 26156025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling the patient and health system impacts of alternative xpert® MTB/RIF algorithms for the diagnosis of pulmonary tuberculosis in Addis Ababa, Ethiopia.
    Tesfaye A; Fiseha D; Assefa D; Klinkenberg E; Balanco S; Langley I
    BMC Infect Dis; 2017 May; 17(1):318. PubMed ID: 28464797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the Xpert MTB/RIF assay for diagnosis of tuberculosis and rifampin resistance in county-level laboratories in Hunan province, China.
    Hu P; Bai L; Liu F; Ou X; Zhang Z; Yi S; Chen Z; Gong D; Liu B; Guo J; Tan Y
    Chin Med J (Engl); 2014; 127(21):3744-50. PubMed ID: 25382330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteriologically confirmed pulmonary tuberculosis patients: Loss to follow-up, death and delay before treatment initiation in Bulawayo, Zimbabwe from 2012-2016.
    Mugauri H; Shewade HD; Dlodlo RA; Hove S; Sibanda E
    Int J Infect Dis; 2018 Nov; 76():6-13. PubMed ID: 30030177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementing the Xpert® MTB/RIF Diagnostic Test for Tuberculosis and Rifampicin Resistance: Outcomes and Lessons Learned in 18 Countries.
    Ardizzoni E; Fajardo E; Saranchuk P; Casenghi M; Page AL; Varaine F; Kosack CS; Hepple P
    PLoS One; 2015; 10(12):e0144656. PubMed ID: 26670929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of new tuberculosis diagnostic technologies on community-based intensified case finding: a multicentre randomised controlled trial.
    Calligaro GL; Zijenah LS; Peter JG; Theron G; Buser V; McNerney R; Bara W; Bandason T; Govender U; Tomasicchio M; Smith L; Mayosi BM; Dheda K
    Lancet Infect Dis; 2017 Apr; 17(4):441-450. PubMed ID: 28063795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The risk and timing of tuberculosis diagnosed in smear-negative TB suspects: a 12 month cohort study in Harare, Zimbabwe.
    Dimairo M; MacPherson P; Bandason T; Zezai A; Munyati SS; Butterworth AE; Mungofa S; Rusikaniko S; Fielding K; Mason PR; Corbett EL
    PLoS One; 2010 Jul; 5(7):e11849. PubMed ID: 20676374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.